HBOT Conversations:
Join us for interviews with researchers, practitioners, industry experts, and patients to share their stories, successes, and expertise relative to hyperbaric oxygen therapy
Subscribe. Join the discussion. Share the hope.
Listen to or Watch the HBOT Conversations Podcast
Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or scroll down and watch an episode here on the HBOT News website:
Watch the HBOT Conversations Podcast
Subscribe Now, It’s Free !
Recent HBOT News
Clinical Trial – Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury
The purpose of this study is to discover the feasibility of conducting clinical research in
individuals with chronic sequelae following brain injury who are given hyperbaric oxygen.
This study will also look at the outcome of individuals with a chronic stable brain injury
due to trauma, anoxia (lack of oxygen to the brain), or stroke, who are given hyperbaric
oxygen. Outcome measures testing cognitive (memory, etc.) and functional (balance, strength,
etc.) measures will be performed before the hyperbaric sessions, immediately following them,
and 6 months later. The subject will receive 60 hyperbaric sessions, 60 minutes in the
chamber, to a pressure of 1.5 ATA, once daily, Monday through Friday.
Simultaneous coronary and cerebral air embolism after CT-guided core needle biopsy of the lung.
Abstract: An air embolism in the arterial system is a rare but serious sequela of lung biopsy. We describe the case of a patient who presented with acute cardiac and cerebral air embolism, including simultaneous acute ST-segment elevation myocardial infarction, atrial...
Simultaneous coronary and cerebral air embolism after CT-guided core needle biopsy of the lung.
Abstract: An air embolism in the arterial system is a rare but serious sequela of lung biopsy. We describe the case of a patient who presented with acute cardiac and cerebral air embolism, including simultaneous acute ST-segment elevation myocardial infarction, atrial...


